Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)
J Evol Biochem Physiol
.
2022;58(2):623.
doi: 10.1134/S0022093022020284.
Epub 2022 May 16.
Authors
N V Goncharov
1
2
,
K A Vasilyev
3
,
I V Kudryavtsev
4
,
P P Avdonin
5
,
D A Belinskaia
1
,
M A Stukova
3
,
O V Shamova
4
,
P V Avdonin
5
Affiliations
1
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
2
Research Institute of Hygiene, Occupational Pathology and Human Ecology, p/o Kuzmolovsky, Vsevolozhsky District, Leningrad Region, Russia.
3
Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
4
Institute of Experimental Medicine, St. Petersburg, Russia.
5
Koltsov Institute of Development Biology, Russian Academy of Sciences, Moscow, Russia.
PMID:
35599638
PMCID:
PMC9109663
DOI:
10.1134/S0022093022020284
Abstract
[This corrects the article DOI: 10.1134/S0022093022010203.].
© Pleiades Publishing, Ltd. 2022.
Publication types
Published Erratum